FWP
GILD icon

FAS Wealth Partners’s Gilead Sciences GILD Stock Holding History

FAS Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Hold
0
– -$111K – 519
2025
Q3 		– Hold
0
– – – 336

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

FAS Wealth Partners's GILD Position: Q1 2026 in Review

FAS Wealth Partners opened a new position in Gilead Sciences (GILD) in Q1 2026: 1,840 shares worth $256K. The stake represents 0.02% of the portfolio and ranks #310 among its holdings. This is a return to the name: FAS Wealth Partners previously reported a position in GILD as recently as Q3 2025.

FAS Wealth Partners first reported a position in GILD in Q3 2025 and has held it in 2 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • FAS Wealth Partners held 1,840 shares of Gilead Sciences worth $256K as of Q1 2026.
  • Gilead Sciences was a new FAS Wealth Partners position in Q1 2026.
  • Gilead Sciences made up 0.02% of FAS Wealth Partners's portfolio in Q1 2026, its #310 holding.
  • FAS Wealth Partners first reported a position in Gilead Sciences in Q3 2025 and has held it in 2 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on FAS Wealth Partners's 13F filing for Q1 2026, filed 10 Jun 2026.